Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease.

PubWeight™: 6.60‹?› | Rank: Top 1%

🔗 View Article (PMID 17785178)

Published in Neuron on September 06, 2007

Authors

Jorge J Palop1, Jeannie Chin, Erik D Roberson, Jun Wang, Myo T Thwin, Nga Bien-Ly, Jong Yoo, Kaitlyn O Ho, Gui-Qiu Yu, Anatol Kreitzer, Steven Finkbeiner, Jeffrey L Noebels, Lennart Mucke

Author Affiliations

1: Gladstone Institute of Neurological Disease, San Francisco, CA 94158, USA. jpalop@gladstone.ucsf.edu

Associated clinical trials:

Levetiracetam and Memory Function in Amnestic Mild Cognitive Impairment (MCI) | NCT01044758

Network-Level Mechanisms for Preclinical Alzheimer's Disease Development | NCT03461861

Levetiracetam for Alzheimer's Disease Neuropsychiatric Symptoms Related to Epilepsy Trial (LAPSE) (LAPSE) | NCT04004702

Articles citing this

(truncated to the top 100)

Neurodegenerative diseases target large-scale human brain networks. Neuron (2009) 9.69

Amyloid deposition is associated with impaired default network function in older persons without dementia. Neuron (2009) 7.02

Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat Neurosci (2010) 5.03

Soluble oligomers of amyloid Beta protein facilitate hippocampal long-term depression by disrupting neuronal glutamate uptake. Neuron (2009) 3.94

Immune activation in brain aging and neurodegeneration: too much or too little? Neuron (2009) 3.76

Amyloid-β and tau--a toxic pas de deux in Alzheimer's disease. Nat Rev Neurosci (2010) 3.61

Blinders, phenotype, and fashionable genetic analysis: a critical examination of the current state of epilepsy genetic studies. Epilepsia (2011) 3.49

Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci (2010) 3.36

Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature (2010) 3.36

Neuronal calcium mishandling and the pathogenesis of Alzheimer's disease. Trends Neurosci (2008) 3.25

Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell (2012) 3.16

Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol (2009) 3.12

Probing the biology of Alzheimer's disease in mice. Neuron (2010) 2.96

Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. J Neurosci (2011) 2.96

Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci (2012) 2.92

Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment. Neuron (2012) 2.89

Levetiracetam suppresses neuronal network dysfunction and reverses synaptic and cognitive deficits in an Alzheimer's disease model. Proc Natl Acad Sci U S A (2012) 2.84

Functional alterations in memory networks in early Alzheimer's disease. Neuromolecular Med (2010) 2.77

Neurotoxicity of amyloid β-protein: synaptic and network dysfunction. Cold Spring Harb Perspect Med (2012) 2.77

Issues related to symptomatic and disease-modifying treatments affecting cognitive and neuropsychiatric comorbidities of epilepsy. Epilepsia (2013) 2.39

Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses. Nat Neurosci (2009) 2.31

Longitudinal fMRI in elderly reveals loss of hippocampal activation with clinical decline. Neurology (2010) 2.25

Early functional impairment of sensory-motor connectivity in a mouse model of spinal muscular atrophy. Neuron (2011) 2.19

New views of Arc, a master regulator of synaptic plasticity. Nat Neurosci (2011) 2.18

Reimagining Alzheimer's disease--an age-based hypothesis. J Neurosci (2010) 2.12

Transsynaptic progression of amyloid-β-induced neuronal dysfunction within the entorhinal-hippocampal network. Neuron (2010) 2.10

Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer's disease. Nat Neurosci (2008) 2.09

Apolipoprotein E and apolipoprotein E receptors: normal biology and roles in Alzheimer disease. Cold Spring Harb Perspect Med (2012) 2.01

Functional network disruption in the degenerative dementias. Lancet Neurol (2011) 1.98

Molecular mechanisms of neurodegeneration in Alzheimer's disease. Hum Mol Genet (2010) 1.90

Relationships between β-amyloid and functional connectivity in different components of the default mode network in aging. Cereb Cortex (2011) 1.87

Alzheimer's disease: synaptic dysfunction and Abeta. Mol Neurodegener (2009) 1.73

Physiologic brain activity causes DNA double-strand breaks in neurons, with exacerbation by amyloid-β. Nat Neurosci (2013) 1.72

Disrupted energy metabolism and neuronal circuit dysfunction in cognitive impairment and Alzheimer's disease. Lancet Neurol (2010) 1.71

Arc in synaptic plasticity: from gene to behavior. Trends Neurosci (2011) 1.69

Beta-amyloid modulation of synaptic transmission and plasticity. J Neurosci (2007) 1.68

Imbalance between GABAergic and Glutamatergic Transmission Impairs Adult Neurogenesis in an Animal Model of Alzheimer's Disease. Cell Stem Cell (2009) 1.68

Seizures and epileptiform activity in the early stages of Alzheimer disease. JAMA Neurol (2013) 1.68

Hippocampal sharp wave-ripple: A cognitive biomarker for episodic memory and planning. Hippocampus (2015) 1.63

The ketogenic diet as a treatment paradigm for diverse neurological disorders. Front Pharmacol (2012) 1.61

Critical role of soluble amyloid-β for early hippocampal hyperactivity in a mouse model of Alzheimer's disease. Proc Natl Acad Sci U S A (2012) 1.58

Amyloid beta-protein toxicity and the pathogenesis of Alzheimer disease. J Biol Chem (2008) 1.57

ApoE4 reduces glutamate receptor function and synaptic plasticity by selectively impairing ApoE receptor recycling. Proc Natl Acad Sci U S A (2010) 1.57

Synapses and Alzheimer's disease. Cold Spring Harb Perspect Biol (2012) 1.57

Neprilysin overexpression inhibits plaque formation but fails to reduce pathogenic Abeta oligomers and associated cognitive deficits in human amyloid precursor protein transgenic mice. J Neurosci (2009) 1.54

A perfect storm: Converging paths of epilepsy and Alzheimer's dementia intersect in the hippocampal formation. Epilepsia (2011) 1.53

Arc regulates spine morphology and maintains network stability in vivo. Proc Natl Acad Sci U S A (2010) 1.51

Neuroimaging markers for the prediction and early diagnosis of Alzheimer's disease dementia. Trends Neurosci (2011) 1.51

Impairments in remote memory stabilization precede hippocampal synaptic and cognitive failures in 5XFAD Alzheimer mouse model. Neurobiol Dis (2008) 1.50

Cystatin C-cathepsin B axis regulates amyloid beta levels and associated neuronal deficits in an animal model of Alzheimer's disease. Neuron (2008) 1.49

Surviving hilar somatostatin interneurons enlarge, sprout axons, and form new synapses with granule cells in a mouse model of temporal lobe epilepsy. J Neurosci (2009) 1.49

Tau overexpression impacts a neuroinflammation gene expression network perturbed in Alzheimer's disease. PLoS One (2014) 1.46

Long-lasting adaptations of the NR2B-containing NMDA receptors in the dorsomedial striatum play a crucial role in alcohol consumption and relapse. J Neurosci (2010) 1.46

Advancing the understanding of autism disease mechanisms through genetics. Nat Med (2016) 1.45

Many neuronal and behavioral impairments in transgenic mouse models of Alzheimer's disease are independent of caspase cleavage of the amyloid precursor protein. J Neurosci (2010) 1.44

The CAMKK2-AMPK kinase pathway mediates the synaptotoxic effects of Aβ oligomers through Tau phosphorylation. Neuron (2013) 1.43

The expression of GABAA beta subunit isoforms in synaptic and extrasynaptic receptor populations of mouse dentate gyrus granule cells. J Physiol (2007) 1.42

Degeneration and repair in central nervous system disease. Nat Med (2010) 1.42

Hippocampal hyperactivation associated with cortical thinning in Alzheimer's disease signature regions in non-demented elderly adults. J Neurosci (2011) 1.41

Sensory network dysfunction, behavioral impairments, and their reversibility in an Alzheimer's β-amyloidosis mouse model. J Neurosci (2011) 1.41

Cyclooxygenase inhibition targets neurons to prevent early behavioural decline in Alzheimer's disease model mice. Brain (2016) 1.41

The dysregulation of intracellular calcium in Alzheimer disease. Cell Calcium (2010) 1.40

CSF biomarker and PIB-PET-derived beta-amyloid signature predicts metabolic, gray matter, and cognitive changes in nondemented subjects. Cereb Cortex (2011) 1.38

Brain imaging in Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.37

Synaptic activity reduces intraneuronal Abeta, promotes APP transport to synapses, and protects against Abeta-related synaptic alterations. J Neurosci (2009) 1.37

Biochemical and immunohistochemical analysis of an Alzheimer's disease mouse model reveals the presence of multiple cerebral Abeta assembly forms throughout life. Neurobiol Dis (2009) 1.37

Rapid target-specific remodeling of fast-spiking inhibitory circuits after loss of dopamine. Neuron (2011) 1.34

Seizures in Alzheimer disease: who, when, and how common? Arch Neurol (2009) 1.34

Enkephalin elevations contribute to neuronal and behavioral impairments in a transgenic mouse model of Alzheimer's disease. J Neurosci (2008) 1.33

Reelin signaling antagonizes beta-amyloid at the synapse. Proc Natl Acad Sci U S A (2009) 1.32

Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice. J Neurosci (2011) 1.32

Initial loss but later excess of GABAergic synapses with dentate granule cells in a rat model of temporal lobe epilepsy. J Comp Neurol (2010) 1.30

Astrocytic regulation of glutamate homeostasis in epilepsy. Glia (2012) 1.26

Nicotinic ACh receptors as therapeutic targets in CNS disorders. Trends Pharmacol Sci (2015) 1.26

GABA(A) receptor-mediated acceleration of aging-associated memory decline in APP/PS1 mice and its pharmacological treatment by picrotoxin. PLoS One (2008) 1.26

Oligomeric Aβ-induced synaptic dysfunction in Alzheimer's disease. Mol Neurodegener (2014) 1.24

Amyloid-beta-induced ion flux in artificial lipid bilayers and neuronal cells: resolving a controversy. Neurotox Res (2009) 1.24

Hilar GABAergic interneuron activity controls spatial learning and memory retrieval. PLoS One (2012) 1.24

Ion channels in genetic and acquired forms of epilepsy. J Physiol (2012) 1.24

Synaptic depression and aberrant excitatory network activity in Alzheimer's disease: two faces of the same coin? Neuromolecular Med (2009) 1.21

Cognition, glucose metabolism and amyloid burden in Alzheimer's disease. Neurobiol Aging (2010) 1.19

Collagen VI protects neurons against Abeta toxicity. Nat Neurosci (2009) 1.19

Transcriptome analysis of synaptoneurosomes identifies neuroplasticity genes overexpressed in incipient Alzheimer's disease. PLoS One (2009) 1.19

Animal models of Alzheimer disease. Cold Spring Harb Perspect Med (2012) 1.18

Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption. J Biol Chem (2009) 1.18

Neurovascular function in Alzheimer's disease patients and experimental models. J Cereb Blood Flow Metab (2011) 1.18

Abnormal neuronal networks and seizure susceptibility in mice overexpressing the APP intracellular domain. Neurobiol Aging (2009) 1.16

Omega-3 fatty acids and dementia. Prostaglandins Leukot Essent Fatty Acids (2009) 1.15

The dendritic hypothesis for Alzheimer's disease pathophysiology. Brain Res Bull (2013) 1.14

Genetic suppression of transgenic APP rescues Hypersynchronous network activity in a mouse model of Alzeimer's disease. J Neurosci (2014) 1.11

APP intracellular domain impairs adult neurogenesis in transgenic mice by inducing neuroinflammation. PLoS One (2010) 1.11

Huntington's Disease. Cold Spring Harb Perspect Biol (2011) 1.11

Selective GABA(A) α5 positive allosteric modulators improve cognitive function in aged rats with memory impairment. Neuropharmacology (2012) 1.10

Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice. J Neurosci (2010) 1.10

Synaptic genes are extensively downregulated across multiple brain regions in normal human aging and Alzheimer's disease. Neurobiol Aging (2012) 1.10

Orchestrated experience-driven Arc responses are disrupted in a mouse model of Alzheimer's disease. Nat Neurosci (2012) 1.08

Expanding functions of lipoprotein receptors. J Lipid Res (2008) 1.07

Phospholipase A2 and arachidonic acid in Alzheimer's disease. Biochim Biophys Acta (2010) 1.07

Lipoprotein receptors--an evolutionarily ancient multifunctional receptor family. Biol Chem (2010) 1.07

Selective vulnerability of neurons in layer II of the entorhinal cortex during aging and Alzheimer's disease. Neural Plast (2010) 1.07

Articles by these authors

SOAP: short oligonucleotide alignment program. Bioinformatics (2008) 68.13

De novo assembly of human genomes with massively parallel short read sequencing. Genome Res (2009) 45.91

A human gut microbial gene catalogue established by metagenomic sequencing. Nature (2010) 43.63

A draft sequence of the rice genome (Oryza sativa L. ssp. indica). Science (2002) 42.78

SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics (2009) 39.47

Enterotypes of the human gut microbiome. Nature (2011) 24.36

SOAPdenovo2: an empirically improved memory-efficient short-read de novo assembler. Gigascience (2012) 20.89

Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res (2008) 20.59

Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences. Proc Natl Acad Sci U S A (2002) 20.48

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Evolution of genes and genomes on the Drosophila phylogeny. Nature (2007) 18.01

SNP detection for massively parallel whole-genome resequencing. Genome Res (2009) 15.96

The sequence and de novo assembly of the giant panda genome. Nature (2009) 15.76

WEGO: a web tool for plotting GO annotations. Nucleic Acids Res (2006) 13.06

Mapping copy number variation by population-scale genome sequencing. Nature (2011) 12.55

A systematic survey of loss-of-function variants in human protein-coding genes. Science (2012) 12.25

Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death. Nature (2004) 11.82

A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature (2012) 11.68

Sequencing of 50 human exomes reveals adaptation to high altitude. Science (2010) 11.27

A roadmap for the prevention of dementia II: Leon Thal Symposium 2008. Alzheimers Dement (2009) 10.21

Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nat Genet (2011) 10.07

TreeFam: a curated database of phylogenetic trees of animal gene families. Nucleic Acids Res (2006) 8.83

Reducing endogenous tau ameliorates amyloid beta-induced deficits in an Alzheimer's disease mouse model. Science (2007) 8.56

The genome of the mesopolyploid crop species Brassica rapa. Nat Genet (2011) 8.23

The genome of the cucumber, Cucumis sativus L. Nat Genet (2009) 8.19

An abundance of rare functional variants in 202 drug target genes sequenced in 14,002 people. Science (2012) 7.94

Genome sequence and analysis of the tuber crop potato. Nature (2011) 7.77

The Genomes of Oryza sativa: a history of duplications. PLoS Biol (2005) 7.67

Ancient human genome sequence of an extinct Palaeo-Eskimo. Nature (2010) 7.51

A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res (2008) 7.45

Regulation of parkinsonian motor behaviours by optogenetic control of basal ganglia circuitry. Nature (2010) 7.35

Open-source genomic analysis of Shiga-toxin-producing E. coli O104:H4. N Engl J Med (2011) 7.11

Richness of human gut microbiome correlates with metabolic markers. Nature (2013) 6.93

TreeFam: 2008 Update. Nucleic Acids Res (2007) 6.63

A draft sequence for the genome of the domesticated silkworm (Bombyx mori). Science (2004) 6.62

Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet (2011) 5.73

Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell (2012) 5.62

Analyses of pig genomes provide insight into porcine demography and evolution. Nature (2012) 5.58

Building the sequence map of the human pan-genome. Nat Biotechnol (2009) 5.53

Resequencing of 200 human exomes identifies an excess of low-frequency non-synonymous coding variants. Nat Genet (2010) 5.44

The oyster genome reveals stress adaptation and complexity of shell formation. Nature (2012) 5.30

Alzheimer mechanisms and therapeutic strategies. Cell (2012) 5.24

A genetic variation map for chicken with 2.8 million single-nucleotide polymorphisms. Nature (2004) 5.24

Resequencing of 31 wild and cultivated soybean genomes identifies patterns of genetic diversity and selection. Nat Genet (2010) 5.20

Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell (2012) 5.16

Dysfunction in GABA signalling mediates autism-like stereotypies and Rett syndrome phenotypes. Nature (2010) 5.11

Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks. Nat Neurosci (2010) 5.03

Inflammation in neurodegenerative disease--a double-edged sword. Neuron (2002) 4.95

Resequencing 50 accessions of cultivated and wild rice yields markers for identifying agronomically important genes. Nat Biotechnol (2011) 4.84

An Aboriginal Australian genome reveals separate human dispersals into Asia. Science (2011) 4.84

Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science (2011) 4.76

Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ (2011) 4.50

Mild overexpression of MeCP2 causes a progressive neurological disorder in mice. Hum Mol Genet (2004) 4.45

Distinct DNA methylomes of newborns and centenarians. Proc Natl Acad Sci U S A (2012) 4.26

The DNA methylome of human peripheral blood mononuclear cells. PLoS Biol (2010) 4.25

Mice lacking Dlx1 show subtype-specific loss of interneurons, reduced inhibition and epilepsy. Nat Neurosci (2005) 4.18

Regression of castrate-recurrent prostate cancer by a small-molecule inhibitor of the amino-terminus domain of the androgen receptor. Cancer Cell (2010) 4.16

KaKs_Calculator: calculating Ka and Ks through model selection and model averaging. Genomics Proteomics Bioinformatics (2006) 4.15

Assemblathon 2: evaluating de novo methods of genome assembly in three vertebrate species. Gigascience (2013) 4.11

Dynamic T cell migration program provides resident memory within intestinal epithelium. J Exp Med (2010) 4.09

Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet (2012) 4.07

Genome-wide patterns of genetic variation among elite maize inbred lines. Nat Genet (2010) 4.06

Whole-genome sequencing in autism identifies hot spots for de novo germline mutation. Cell (2012) 4.03

Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers. Nature (2010) 3.95

Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet (2013) 3.87

Comprehensive analysis of RNA-Seq data reveals extensive RNA editing in a human transcriptome. Nat Biotechnol (2012) 3.83

Comparative population genomics of maize domestication and improvement. Nat Genet (2012) 3.78

Two Dobzhansky-Muller genes interact to cause hybrid lethality in Drosophila. Science (2006) 3.77

Maize HapMap2 identifies extant variation from a genome in flux. Nat Genet (2012) 3.74

Sclerostin mediates bone response to mechanical unloading through antagonizing Wnt/beta-catenin signaling. J Bone Miner Res (2009) 3.69

Epidemiological evidence for the link between sleep duration and high blood pressure: a systematic review and meta-analysis. Sleep Med (2013) 3.68

Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma. Nat Genet (2011) 3.66

TGM6 identified as a novel causative gene of spinocerebellar ataxias using exome sequencing. Brain (2010) 3.66

Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11,105 pregnancies with mixed risk factors. Prenat Diagn (2012) 3.54

Draft genome sequence of pigeonpea (Cajanus cajan), an orphan legume crop of resource-poor farmers. Nat Biotechnol (2011) 3.51

Recalibrating Equus evolution using the genome sequence of an early Middle Pleistocene horse. Nature (2013) 3.45

Draft genome sequence of chickpea (Cicer arietinum) provides a resource for trait improvement. Nat Biotechnol (2013) 3.41

Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem (2006) 3.40

Aegilops tauschii draft genome sequence reveals a gene repertoire for wheat adaptation. Nature (2013) 3.40

SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem (2005) 3.38

Reversing EphB2 depletion rescues cognitive functions in Alzheimer model. Nature (2010) 3.36

Deep RNA sequencing at single base-pair resolution reveals high complexity of the rice transcriptome. Genome Res (2010) 3.34

A network dysfunction perspective on neurodegenerative diseases. Nature (2006) 3.33

100 years and counting: prospects for defeating Alzheimer's disease. Science (2006) 3.24

Genome sequencing reveals insights into physiology and longevity of the naked mole rat. Nature (2011) 3.19

The draft genome of a diploid cotton Gossypium raimondii. Nat Genet (2012) 3.18

Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model. Cell (2012) 3.16

Accelerating amyloid-beta fibrillization reduces oligomer levels and functional deficits in Alzheimer disease mouse models. J Biol Chem (2007) 3.13

Epilepsy and cognitive impairments in Alzheimer disease. Arch Neurol (2009) 3.12

BK channel beta4 subunit reduces dentate gyrus excitability and protects against temporal lobe seizures. Nat Neurosci (2005) 3.05

BioMart Central Portal: an open database network for the biological community. Database (Oxford) (2011) 3.03

Snap: an integrated SNP annotation platform. Nucleic Acids Res (2006) 2.99

Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease. J Neurosci (2011) 2.96